Pimodivir | Interleukin Related interleukin-related.com

Product Name :
Pimodivir

Search keywords :
Pimodivir

drugId :
null

Target Vo:
Polymerase basic protein 2

Target Vo Short Name :
PB2

Moa_Name:
Polymerase basic protein 2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Vertex Pharmaceuticals Incorporated

Active Company_Name :
Janssen-Cilag International Nv

Active Indication_Name:
Hepatic Insufficiency

In Active Indication_Name:
Influenza A virus infections

Termination Status :

China Termination Status :
Phase 3 Clinical

Highest Status:
Phase 1 Clinical

China Highest Status:
Discontinued

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Dihydrouracil-d4 Formula
Phospho-c-Myc(S62) Rabbit mAb Biological Activity
Lyn Antibody (YA707): Lyn Antibody (YA707) is a non-conjugated and Mouse origined monoclonal antibody about 59 kDa, targeting to Lyn (1C8). It can be used for WB assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts